Showing results (691-700 of 705) with videos related to
Sort By:
Pageof 71
Cancer Discovery|October 26, 2019
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic CancerG Aaron Hobbs, Nicole M Baker, Anne M Miermont, et al.JAMA Oncology|November 12, 2020
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled TrialJules Lansu, Judith V M G Bovée, Pètra Braam, et al.Cancer Discovery|February 6, 2023
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor AlphaAvinash Sahu, Xiaoman Wang, Phillip Munson, et al.Journal of Hepatology|May 8, 2010
Differences in presentation and progression between severe FIC1 and BSEP deficienciesLudmila Pawlikowska, Sandra Strautnieks, Irena Jankowska, et al.Nature Medicine|June 3, 2020
Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancerKirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.Nature Medicine|March 6, 2019
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancerKirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.Human Molecular Genetics|September 22, 2018
GLS hyperactivity causes glutamate excess, infantile cataract and profound developmental delayLynne Rumping, Federico Tessadori, Petra J W Pouwels, et al.Cancer Cell|December 12, 2023
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sitesTalya L Dayton, Nicolas Alcala, Laura Moonen, et al.Cell Reports|June 30, 2021
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibitionAndrew M Waters, Tala O Khatib, Bjoern Papke, et al.Cell Reports. Medicine|April 26, 2024
Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastasesSanne Bootsma, Mark P G Dings, Job Kesselaar, et al.Pageof 71